CardioTech/Gish
This article was originally published in The Gray Sheet
Executive Summary
CardioTech will use Gish clean room facilities to manufacture polyurethane coronary artery bypass grafts after acquiring the Rancho Santa Margarita, California heart surgery products company for about $7.3 mil. in stock on Oct. 30. The deal also will increase CardioTech revenues by over 500%. CardioTech reported revenue of $3.2 mil. for the year ended March 31, while Gish had sales of $16 mil. in 2001...